Corinna Lathan - 09 Jun 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Director
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol: EKSO
Transactions as of: 09 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 18 Jul 2022, 18:37:57 UTC
Previous filing: 11 Feb 2022
Next filing: 17 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Award	$0	+51,721	+3.42%	$0	66,865	09 Jun 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2	This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Content

Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.